Lentiviruses induce a wide range of diseases in animals and are the cause of human acquired immunodeficiency syndrome (AIDS). Although they vary greatly in disease potential, the various lentiviruses have many things in common. One common feature appears to be their genetic plasticity. Frequent genetic mutations lead to the loss of nucleotide sequence homology not only among various types of lentiviruses but also among isolates from the same species (2) . Antigenic changes are most noticeable in the largeenvelope region of the genome. Envelope mutations are particularly relevant to equine infectious anemia virus infection of horses. In this infection, there are cyclic waves of recurrent fever and anemia, each associated with new envelope variants that are no longer neutralized by antibodies to the parent viruses (7, 10) . For Maedi-visna virus infection of sheep, genetic variants appear during the course of infection but coexist in the blood with the parent strain and do not displace it (8) .
Human immunodeficiency virus (HIV) also appears to spontaneously mutate at a high rate (8) . Genetic variation has been demonstrated for HIV isolated from different patients, from the same individuals over time, and from different individuals exposed to the same virus source (4, 11) . As is the case with animal lentiviruses, genomic diversity seems to be the greatest in the envelope region of HIV (3; A. Srinivasan, R. Anand, D. York, R. Ferguson, J. Curran, and D. Butler, Jr., Abstr. Int. Conf. AIDS, p. 12, 1986) .
Although genetic diversification is common with HIV, it is still not known whether genetic variants occur in vivo and displace the parent virus, as is the case for equine infectious anemia virus, or whether mutant and parent strains coexist in the same host, as has been observed for Maedi-visna * Corresponding author.
virus. Such a determination is possible, however, by use of either serologic or molecular genetic techniques. The classic serologic technique for detecting antigenic variants has been that of antibody-mediated virus neutralization. To date, most HIV isolates are sufficiently closely related to each other that cross-neutralization with immune human serum is very common and is of limited help in differentiating variants. It is possible, however, to use serologic techniques to detect antigenic markers in regions other than the envelope. In our laboratory, we identified combinations of monoclonal antibodies that detected a specific antigenic marker present in the p24 region of HIV isolates resembling the AIDSassociated retrovirus type 2 strain of HIV (HIV ARV-2) (5).
Recent studies in our laboratory have involved the use of these unique epitopic markers in the p24 region of HIV to detect variants of HIV in cultures of peripheral blood mononuclear cells (PBMC) from a large number of HIVseropositive individuals. This technique can also be used to detect multiple HIV variants within a primary culture from a single patient. The purpose of this report is to describe two patients, each of whom yielded at least two different HIV variants from a single blood sample.
MATERIALS AND METHIODS
Virus purification. The human T-cell lymphotrophic virus type III strain of HIV (HIV HTLV-III), propagated in H9 cells, was provided by R. C. Gallo (9) . The lymphadenopathy-associated virus type 1 strain of HIV (HIV LAV-1) was provided by F. Barré-Sinoussi (1) Coexistence of antigenic HIV variants. We tested whether the original PBMC culture supernatants contained more than one HIV p24 variant. To do this, we used a rabbit polyclonal anti-HIV serum that had high levels of p24 antibodies. The binding of these antibodies to p24 in a sandwich assay was inhibited by the prior binding of monoclonal antibody 22-3. Virus-containing supernatants were pretreated or not pretreated with 22-3 and tested in a double-sandwich ELISA with the monoclonal 22-6 HIV p24 antibody as the capture antibody and polyclonal rabbit anti-HIV immunoglobulin conjugated to horseradish peroxidase as the labeled second antibody. If the 22-3 HIV HTLV-III p24 epitope was present on the virus or viruses in the supernatants, the 22-3 antibody would bind and interfere with the subsequent binding of the labeled rabbit polyclonal antibody. If 22-3 antibody was not bound, as would be the case if the supernatant contained the 22-3 HIV ARV-2 p24 epitope, then there would be no interference with the binding of the rabbit polyclonal antibody. As a standard for the assay, mixtures of HIV HTLV-III and HIV ARV-2 were made in the ratio 4:0, 3:1, 2:2, 1:3, and 0:4 and tested in the 22-3 monoclonal antibody interference assay described above. As a control, the mixtures were also treated with 22-6 monoclonal antibody, which inhibited the binding of p24 to the ELISA wells whether the virus was HTLV-III-like or ARV-2 like. Addition of 22-3 monoclonal antibody interfered with the binding of the rabbit polyclonal antibody as the proportion of HIV HTLV-III in the mixture increased (Table 3) . (Fig. 1) . The 237-PBMC and 260-PBMC isolates reacted with both the 22-6 and 22-3 monoclonal antibodies, while the 237-PBMC-H9 and 260-PBMC-H9 isolates reacted with the 22-6 but not the 22-3 monoclonal antibody. The 237-PBMC-H9-PBMC and 260-PBMC-H9-PBMC isolates also reacted only with the 22-6 monoclonal antibody (Fig. 1) .
We concluded, therefore, that H9 cells selectively allowed for the replication of at least one variant in the original PBMC culture supernatants and that the other variants failed to replicate and were not detected.
DISCUSSION
It appears that several HIV p24 variants can be isolated simultaneously from a single PBMC culture from the same patient. The coexistence of distinctly different genetic variants in primary cultures sampled at an early passage indicates that they did not arise from mutations occurring after the cultures were initiated. As such, they probably coexisted in the blood of the patients at the time of sampling. This situation resembles Maedi-visna virus infection in sheep, in which genetic variants often coexist (8) . It is possible, however, that the presence of two or more genetic variants in the blood of the patients did not involve intrinsic genetic drift. The p24 epitope characteristic of HIV ARV-2 is also present in about one-fourth of the HIV isolates from the California area (5). Given the frequency of this epitope and the opportunity for multiple infectious exposures among high-risk groups, variants in the blood of an individual patient could also arise from coinfections. Coinfections with multiple genetic variants are more likely to occur when genetic differences are small and not in the envelope region, Int. Conf. AIDS, 1986) .
The fact that the 22-3 epitopic marker exists in the p24 of HIV is unusual, given the high degree of conservation within the gag region of the genome. Genetic mutations are apparently more likely to occur in the env region of the genome. Hahn et al. (4) , using Southern blot genomic analysis, molecular cloning, and nucleotide sequencing, studied the genetic makeup of four to six sequential isolates from three individuals over a period of 1 to 2 years. They noticed a distinct tendency for sequential isolates to drift genetically away from the original isolates and estimated the rate of evolution of HIV as at least 1i-0 nucleotide substitutions per site per year for the envelope gene and 10-4 for the gag genes. Hahn et al. (4) 
